Francesco Amadei

Parma, 43122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of Bronchiectasis.

Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of Bronchiectasis.

Journal: Journal of medicinal chemistry

Published: November 27, 2025

Direct powder extrusion (DPE) 3D-printing of mini-tablets for preclinical studies in rodents.

Direct powder extrusion (DPE) 3D-printing of mini-tablets for preclinical studies in rodents.

Journal: International journal of pharmaceutics

Published: January 16, 2025

Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.

Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.

Journal: Journal of medicinal chemistry

Published: June 10, 2024

Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.

Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.

Journal: Journal of medicinal chemistry

Published: August 10, 2023

Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease.

Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease.

Journal: Journal of medicinal chemistry

Published: June 18, 2021

Pulmonary Surfactant: A Unique Biomaterial with Life-saving Therapeutic Applications.

Pulmonary Surfactant: A Unique Biomaterial with Life-saving Therapeutic Applications.

Journal: Current medicinal chemistry

Published: March 05, 2021

Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases.

Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases.

Journal: Journal of medicinal chemistry

Published: December 05, 2017

In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration.

In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration.

Journal: Pediatric research

Published: April 21, 2017

Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.

Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.

Journal: Journal of medicinal chemistry

Published: January 10, 2014

Impact of drug administration route on drug delivery and distribution into the lung: an imaging mass spectrometry approach.

Impact of drug administration route on drug delivery and distribution into the lung: an imaging mass spectrometry approach.

Journal: European journal of mass spectrometry (Chichester, England)

Published: January 01, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026